Champions Oncology Inc (STU:2I3)
€ 4 0.1 (2.56%) Market Cap: 55.93 Mil Enterprise Value: 59.94 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 72/100

Q3 2023 Champions Oncology Inc Earnings Call Transcript

Mar 16, 2023 / NTS GMT
Release Date Price: €3.74 (-3.11%)
Operator

Good day, everyone, and welcome to the Champions Oncology third quarter fiscal year 2023 earnings call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, Dr. Ronnie Morris, Chief Executive Officer of Champions Oncology. Sir, the floor is yours.

Ronnie Morris
Champions Oncology Inc. - President & CEO

Good afternoon. I'm Ronnie Morris, CEO of Champions Oncology. Joining me today is David Miller, our Chief Financial Officer. Thank you for joining us for our quarterly earnings call. Before I begin, I want to remind you that we may make some forward-looking statements during today's call and that actual results could differ materially from what is described in those statements.

Additional information on (inaudible) that could cause results to differ available in our Form 10-Q and Form 10-K. Our reconciliation of non-GAAP financial measures that need to be discussed during the call and the GAAP financial measures will be available in the earnings release. Overall, our financial results were weaker than the previous quarter.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot